Cargando…
Long-term every-other-day administration of DMAMCL has little effect on aging and age-associated physiological decline in mice
The activation of transcription factor NF-κB is currently identified as one of the driving forces to the aging process. Genetic impairment of NF-κB signaling pathway or pharmacological inhibition of NF-κB activity has been shown to extend healthspan and lifespan in animal models, and delay or reduce...
Autores principales: | Sun, Zhaomeng, Zhao, Lijun, Su, Li, Fang, Qing, Xu, Chenzhong, Su, Yuanyuan, Liang, Yao, Li, Guodong, Xue, Yanxue, Tong, Tanjun, Chen, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535057/ https://www.ncbi.nlm.nih.gov/pubmed/31048563 http://dx.doi.org/10.18632/aging.101932 |
Ejemplares similares
-
S100A13 promotes senescence-associated secretory phenotype and cellular senescence via modulation of non-classical secretion of IL-1α
por: Su, Yuanyuan, et al.
Publicado: (2019) -
hnRNP A1 antagonizes cellular senescence and senescence‐associated secretory phenotype via regulation of SIRT1 mRNA stability
por: Wang, Hui, et al.
Publicado: (2016) -
Micheliolide Derivative DMAMCL Inhibits Glioma Cell Growth In Vitro and In Vivo
por: An, Yinghong, et al.
Publicado: (2015) -
HnRNP F/H associate with hTERC and telomerase holoenzyme to modulate telomerase function and promote cell proliferation
por: Xu, Chenzhong, et al.
Publicado: (2019) -
Correction to: HnRNP F/H associate with hTERC and telomerase holoenzyme to modulate telomerase function and promote cell proliferation
por: Xu, Chenzhong, et al.
Publicado: (2021)